![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 24, 21715-21720, June 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
rünç
From the Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7260
Received for publication, March 11, 2003
, and in revised form, April 8, 2003.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Much of our current understanding about the checkpoint control pathways is drawn from studies in budding and fission yeast. Despite some differences between yeast and mammalian cells, the major components of this protein network appear to be the same. Mus81 was initially identified by two independent yeast-two hybrid screens with S. cerevisiae Rad54 (7) and S. pombe Cds1 (homolog of human Chk2) (8) used as bait. Chk2, defined as a transducer protein in the checkpoint signal transduction pathway, is a Ser/Thr protein kinase (9, 10, 11, 12). Incomplete replication is monitored by checkpoint damage sensor proteins, which either activate Chk2 and ensure a reversible S phase arrest or activate both Chk1 and Chk2 to establish a G2/M arrest (13). Studies in yeast indicate that Rad53, budding yeast homolog of Chk2, is required for the stalled replication fork recovery (14). Current models suggest that the S phase checkpoint activates the recombinational repair machinery instead of indirectly allowing repair by inhibiting replication (6). Rad54, a double-stranded DNA-dependent ATPase, works together with the Rad52 epistatic group proteins in the recombinational repair of double-strand DNA breaks (15). The properties of these two Mus81-interacting proteins, Chk2 and Rad54, strongly suggest that MUS81 plays a role in the S phase recovery pathway.
MUS81 has high homology to the XPF family of nucleases (16, 17, 18). The XPF protein forms a stable heterodimer with its binding partner, ERCC1, and this complex is required for the 5' nuclease activity during nucleotide excision repair (19, 20). A Mus81 binding partner has been reported in both budding and fission yeast as Mms4 and Eme1, respectively (21, 22). These complexes are capable of resolving a variety of fork structures that may arise during replication fork arrest or recombination, including Holliday structures (23).
Human MUS81 was previously identified, and partially purified hMUS81 was shown to cleave fork structures (24, 25). There were no biochemical data that the human MUS81 preparation contained hMMS4, and standard data base searches failed to reveal a human ortholog (24, 25). Here we have used bioinformatics approaches to identify a human ortholog of Mms4/Eme1. Furthermore, we show that although hMUS81 has no nuclease activity on its own, the protein, which we designate hMMS4, forms a heterodimer with hMUS81, and this hMUS81-hMMS4 heterodimer has a structure-specific endonuclease activity. We conclude that the newly identified human protein is a functional homolog of yeast Mms4/Eme1, which confers specific endonuclease activity to hMUS81.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The results of PSI-PHI BLAST and 3D-PSSM (three-dimensional position-specific scoring matrix) searches using SpEme1 and ScMms4 sequences against the human genome data base showed that the IMAGE clone MGC: 9497 was a statistically significant candidate. The open reading frame of the putative human MMS4 gene was amplified from pCMV.SPORT6-MMS4 plasmid (Invitrogen), which contains the IMAGE clone MGC: 9497, using primers 5'-GCAACAAAGCTTAGCCACCATGTACCCATACGACGTCCCAGACTACGCTGCTCTAAAGACATCACCCTCACTG-3' and 5'-CTTTAGCCGCTCGAGTTAATGATGATGATGATGATGGTCAGCA CTATCTAAAG-3'. The PCR product was digested with HindIII and XhoI enzymes and then inserted into pcDNA4/myc-HisA vector to obtain the N-terminal HA1-tagged and C-terminal His-tagged hMMS4 expression vector pcDNA4-HA-hMMS4-His. Both the N- and C-terminal tags were obtained from the PCR primers. The C-terminal primer encodes for a His tag and a stop codon at the end. PCR-generated sequences were verified by DNA sequencing (University of North Carolina at Chapel Hill DNA Sequencing Facility). The control plasmid used for immunoprecipitation experiments, FLAG-hCRY1-myc/His, has been described previously (26).
DNA SubstratesDNA substrates were prepared from HPLC-purified 50-mer DNA oligos (OPERON Technologies) as Oligo 1, 5'-GACGCTGCCGAATTCTGGCTTGCTAGGACATCTTTGCCCACGTTGACCCG-3'; Oligo 2, 5'-GCGATAGTCTCTAGACAGCATGTCCTAGCAAGCCAGAATTCGGCA GCGTC-3'; and Oligo 3, CGGGTCAACGTGGGCAAAGATGTCCTAG CAAGCCAGAATTCGGCAGCGTC. The underlined nucleotides in Oligo 2 are complementary to those in the Oligo 1. The single-stranded DNA was made by labeling and purifying Oligo 1. The double-stranded DNA was made by annealing labeled Oligo 1 with Oligo 3. The Y structure was made by annealing Oligo 1 with Oligo 2. Oligo1 (1 pmol) was labeled at the 5' terminus using 1 mCi [
-32P]ATP (ICN, 7000 Ci/mmol) and T4 polynucleotide kinase (New England Biolabs). Following kinase inactivation, the labeled Oligo 1 was gel-purified on 10% denaturing gel and annealed with an excess of cold Oligo 4. Then, double-stranded 50-mers were gel-purified from a 5% non-denaturing polyacrylamide gel.
Cell Culture, Expression of Recombinant Proteins, and ImmunoprecipitationThe SV40-transformed human embryonic kidney 293 (293T) cells were maintained in Dulbecco's modified Eagle's medium with high glucose (Invitrogen) supplemented with 10% fetal bovine serum and 100 units of penicillin and streptomycin/ml. 4 x 106 293T cells were plated on 150 cm2 plates 1 day prior to transfection. Cells were transfected with either pcDNA4-FLAG-hMUS81-His or pcDNA4-HA-hMMS4-His mammalian expressions vectors or both of these vectors (15 µg plasmid DNA each) using the calcium-phosphate precipitation protocol (27). After 10 h of incubation at 37 °C in 5% CO2, fresh medium was added to the cells, and incubation was continued for a further 3648 h. Cells were washed once with cold phosphate-buffered saline and then were harvested and pelleted. The pellet was lysed using lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM
-glycerophosphate, 10% glycerol, 1% Tween 20, 0.1% Nonidet P-40, 1 mM Na3VO4, 1 mM NaF, and EDTA-free protease inhibitors (Roche Molecular Biochemicals)) for 20 min. The cell lysates were centrifuged and the supernatant was bound to 15 µl of washed and activated either HA (Roche Applied Science) or FLAG (Sigma) resin. The resin was washed and activated prior to use according to the manufacturer's protocol. The lysates were incubated with the beads rocking at 4 C° for 610 h. Then, the beads were washed three times with 1 ml of lysis buffer and three times with 1 ml of nuclease buffer, which is described below. The immunoprecipitates were analyzed on 10% SDS-polyacrylamide gels. Western blots were performed by transferring proteins to Highbond ECL nitrocellulose papers (Amersham Biosciences) using a semi-dry electroblotter. For immunoblotting, His (sc-803)-purified rabbit polyclonal antibody (Santa Cruz Biotechnology) was used followed by antirabbit secondary antibody (Promega) and alkaline phosphotase color development assay (Promega).
Endonuclease AssayThe endonuclase assay was performed using hMUS81, hMMS4, or hMUS81-hMMS4 immunoprecipitates. After washing FLAG and HA immunoprecipitates three times with lysis buffer followed by three times with nuclease buffer (50 mM Tris-HCl, pH 7.5, 100 µg/ml bovine serum albumin, 1 mM
-mercaptoethanol, 2.5 mM MgCl2) (24), and they were incubated with radio-labeled Y structure DNA substrate (1 nM) in 30 µl reaction volume for 1 h at 30 °C, unless otherwise indicated. The reaction was stopped by the addition of 10 µg proteinase K (Roche Applied Science) plus 10% SDS with incubation at 37 °C for 20 min, followed by phenol-chloroform extraction and ethanol precipitation. The products were analyzed on denaturing 10% polyacrylamide gels, and the level of incision was quantified by Phosphor-Imager (Amersham Biosciences) using ImageQuant software.
| RESULTS |
|---|
|
|
|---|
|
MUS81 Binds to MMS4 Specifically to Form a Complex The first step in ascertaining whether MMS4 encodes the human binding partner of MUS81 was to express both MUS81 and MMS4 proteins in mammalian cells to determine whether they interact. Human 293T cells were transfected both with FLAG-MUS81-His and HA-MMS4-His vectors alone and together. After transfection of 293T cells, cell lysates were prepared and Western blotting was performed using His antibodies. In Fig. 2, lanes 14 show cell lysates and expression levels of each protein, and lanes 58 show the results of the immunoprecipitation using FLAG beads. Although HA-MMS4-His was expressed at the same levels in both lanes 2 and 3, only in lane 7 were both hMMS4 and hMUS81 proteins present, indicating that hMMS4 interacts with the FLAG-MUS81 protein but not with the negative control FLAG-CRY1 in lane 6. These results were confirmed by performing the reciprocal immunoprecipitation assay. Immunoprecipitation of hMMS4 pulled down hMUS81 showing that the interaction we detected is specific (Fig. 3A). In lanes 13 cell lysates were immunoprecipitated using HA resin and in lanes 46 they were immunoprecipitated with FLAG resin. Lanes 2 and 4 were used as negative controls for nuclease assay using HA and FLAG resins, respectively. In lanes 1 and 5, HA-MMS4 and FLAG-MUS81 proteins were expressed and immunoprecipitated on their own. In lanes 3 and 6, hMUS81 and hMMS4 were expressed together and pulled-down with either HA or FLAG resins. These results demonstrate that hMMS4 is a binding partner for hMUS81 protein.
|
|
MUS81-MMS4 Is a Structure-specific EndonucleaseNext, we performed nuclease assays with the immunoprecipitates of the FLAG-MUS81-His protein, the HA-MMS4-His protein, and the FLAG-MUS81-His ·HA-MMS4-His protein complex to determine whether these two proteins form a functional nuclease complex. We used Y-structure substrates for our nuclease assays because such a structure is typically used for detecting nuclease activity of structure-specific nucleases such as FEN1 and XPF-ERCC1 (28, 29). The results of the nuclease assay are shown in Fig. 3B. The immunoprecipitates of hMUS81 and hMMS4 or the complex have only minor nonspecific nuclease activity on either single-stranded DNA (lanes 13) or double-stranded DNA (lanes 46). Immunoprecipitates of the individual proteins also failed to cleave the Y-structure specifically (lanes 7 and 11). In contrast, immunoprecipitates that contained both hMus81 and hMMS4 incised the Y-structure at the junction of single-stranded DNA to double-stranded DNA specifically (lanes 9 and 12). These results show that hMMS4 not only binds to hMUS81, but also forms a functional complex that incises Y-shaped DNA structure in a specific manner common to this family of nucleases.
Because a previous report (24) indicated that hMUS81 immunoprecipitates had junction cutting activity, we performed a kinetic assay to detect any low level of activity that might have been missed in Fig. 3B. HA-immunoprecipitated MUS81 · MMS4 complex was used because HA resin immunoprecipitates resulted in better complex formation and higher nuclease activity (Fig. 3C). In Fig. 4A, lanes 14, DNA substrate and/or FLAG- and HA-immunoprecipitated cell lysates were incubated for 60 min. HA-immunoprecipitated MUS81 ·MMS4 protein complex was incubated for 15, 30, 45, and 60 min (lanes 58). As seen in Fig. 4A (lanes 58), only the MUS81 ·MMS4 complex cuts the DNA specifically. Quantitative analysis of this data (Fig. 4B) shows that MUS81 alone had less than 5% of the nuclease activity of MUS81 ·MMS4 complex. Thus, we conclude that the MUS81 ·MMS4 complex is the functional form of MUS81 resolvase.
|
| DISCUSSION |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The on-line version of this article (available at http://www.jbc.org) contains Supplemental Table I. ![]()
To whom correspondence should be addressed: Dept. of Biochemistry and Biophysics, University of North Carolina, School of Medicine, Chapel Hill, NC 27599-7260. Tel.: 919-962-0115; E-mail: Aziz_Sancar{at}med.unc.edu.
1 The abbreviation used is: HA, hemagglutinin. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. H. Chang, J. J. Kim, J. M. Choi, J. H. Lee, and Y. Cho Crystal structure of the Mus81-Eme1 complex Genes & Dev., April 15, 2008; 22(8): 1093 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Ehmsen and W.-D. Heyer Saccharomyces cerevisiae Mus81-Mms4 is a catalytic, DNA structure-selective endonuclease Nucleic Acids Res., April 1, 2008; 36(7): 2182 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inagaki, C. Ma, T. A. Storm, M. A. Kay, and H. Nakai The Role of DNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice J. Virol., October 15, 2007; 81(20): 11304 - 11321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pamidi, R. Cardoso, A. Hakem, E. Matysiak-Zablocki, A. Poonepalli, L. Tamblyn, B. Perez-Ordonez, M. P. Hande, O. Sanchez, and R. Hakem Functional Interplay of p53 and Mus81 in DNA Damage Responses and Cancer Cancer Res., September 15, 2007; 67(18): 8527 - 8535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Trowbridge, K. McKim, S. J. Brill, and J. Sekelsky Synthetic Lethality of Drosophila in the Absence of the MUS81 Endonuclease and the DmBlm Helicase Is Associated With Elevated Apoptosis Genetics, August 1, 2007; 176(4): 1993 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hartung, S. Suer, T. Bergmann, and H. Puchta The role of AtMUS81 in DNA repair and its genetic interaction with the helicase AtRecQ4A Nucleic Acids Res., September 11, 2006; 34(16): 4438 - 4448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Allen, S. Buttner, A. D. Aragon, J. A. Thomas, O. Meirelles, J. E. Jaetao, D. Benn, S. W. Ruby, M. Veenhuis, F. Madeo, et al. Isolation of quiescent and nonquiescent cells from yeast stationary-phase cultures J. Cell Biol., July 3, 2006; 174(1): 89 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hiyama, M. Katsura, T. Yoshihara, M. Ishida, A. Kinomura, T. Tonda, T. Asahara, and K. Miyagawa Haploinsufficiency of the Mus81-Eme1 endonuclease activates the intra-S-phase and G2/M checkpoints and promotes rereplication in human cells Nucleic Acids Res., February 2, 2006; 34(3): 880 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dendouga, H. Gao, D. Moechars, M. Janicot, J. Vialard, and C. H. McGowan Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis Mol. Cell. Biol., September 1, 2005; 25(17): 7569 - 7579. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-F. Richard, A. Kerrest, I. Lafontaine, and B. Dujon Comparative Genomics of Hemiascomycete Yeasts: Genes Involved in DNA Replication, Repair, and Recombination Mol. Biol. Evol., April 1, 2005; 22(4): 1011 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Komori, M. Hidaka, T. Horiuchi, R. Fujikane, H. Shinagawa, and Y. Ishino Cooperation of the N-terminal Helicase and C-terminal Endonuclease Activities of Archaeal Hef Protein in Processing Stalled Replication Forks J. Biol. Chem., December 17, 2004; 279(51): 53175 - 53185. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ha, S. Ceryak, and S. R. Patierno Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of {gamma}-H2AX Carcinogenesis, November 1, 2004; 25(11): 2265 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. McPherson, B. Lemmers, R. Chahwan, A. Pamidi, E. Migon, E. Matysiak-Zablocki, M. E. Moynahan, J. Essers, K. Hanada, A. Poonepalli, et al. Involvement of Mammalian Mus81 in Genome Integrity and Tumor Suppression Science, June 18, 2004; 304(5678): 1822 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Blais, H. Gao, C. A. Elwell, M. N. Boddy, P.-H. L. Gaillard, P. Russell, and C. H. McGowan RNA Interference Inhibition of Mus81 Reduces Mitotic Recombination in Human Cells Mol. Biol. Cell, February 1, 2004; 15(2): 552 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Hollingsworth and S. J. Brill The Mus81 solution to resolution: generating meiotic crossovers without Holliday junctions Genes & Dev., January 15, 2004; 18(2): 117 - 125. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |